https://www.selleckchem.com/pr....oducts/alantolactone
PURPOSE To analyze the clinical results of repeat Descemet membrane endothelial keratoplasty (re-DMEK) for failed primary DMEK graft at a referral center for keratoplasty in Spain. DESIGN Retrospective, interventional, comparative case series. METHODS From a single-center, single-surgeon series of 189 consecutive DMEK surgeries, fourteen (7.41%) were re-DMEK eyes. Primary outcome was best-corrected visual acuity change (ΔBCVA,logMAR) from baseline (prior to first DMEK) to last follow-up. Secondary outcomes were ΔBCVA from baseline